TipRanks
Go Ultimate55% OFF

iNtRON Biotechnology, Inc. (048530) Ownership - Who Owns iNtRON Biotechnology, Inc.?

iNtRON Biotechnology, Inc. (048530) Ownership Overview

  • 0.21% Mutual Funds
  • <0.01% ETFs
  • 99.79% Public Companies and Individual Investors

The ownership structure of iNtRON Biotechnology, Inc. (KR:048530) stock is a mix of institutional, retail, and individual investors. Approximately 0.21% of the company’s stock is owned by Institutional Investors, and 99.79% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

KR:048530 top shareholders
Holder# of SharesType% HoldingValue
Dfa Investment Dimensions Group Inc63,527Institution0.21%132,898
Avantis184Institution<0.01%385

Top Mutual Fund Holders

KR:048530 top mutual fund holders
Holder# of SharesType% HoldingValue
Dfa Investment Dimensions Group Inc63,527Institution0.21%132,898

Top ETF Holders

KR:048530 top ETF holders
Holder# of SharesType% HoldingValue
Avantis184Institution<0.01%395

FAQ

What percentage of iNtRON Biotechnology, Inc. (KR:048530) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.79% of iNtRON Biotechnology, Inc. (KR:048530) stock is held by retail investors.
Who owns the most shares of iNtRON Biotechnology, Inc. (KR:048530)?
DFA INVESTMENT DIMENSIONS GROUP INC owns the most shares of iNtRON Biotechnology, Inc. (KR:048530).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.